Results 121 to 130 of about 40,413 (202)

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy. [PDF]

ACS Chem Neurosci
Gregro AR, Park C, Long MF, Baker LA, Bollinger KA, Ringuette AE, Peng L, Luscombe VB, Billard NB, Rodriguez AL, Niswender CM, Peng W, Dickerson JW, Rook JM, O'Neill J, Chang S, Boonen HCM, Jensen T, Thomsen MS, Bridges TM, Boutaud O, Conn PJ, Engers DW, Lindsley CW, Temple KJ.   +24 more
europepmc   +1 more source

Targeting muscarinic receptors in schizophrenia treatment: Novel antipsychotic xanomeline/trospium chloride. [PDF]

World J Psychiatry
Pejčić AV.
europepmc   +1 more source

Central cytometabolic functional vascular coupling in health and disease. [PDF]

NPJ Metab Health Dis
Sims SL, Lu TH, Weiss BE, Lin RL, Galopin LB, Wright NA, Norris CM, Thibault O.   +7 more
europepmc   +1 more source

From sedation to stimulation: anecdotal case reports of enhanced sexual arousal in men and women taking diphenhydramine hydrochloride. [PDF]

Sex Med
Regis MP, Pfaus JG.
europepmc   +1 more source

Correction to: From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]

Int J Neuropsychopharmacol
europepmc   +1 more source

On Vibronic-Driven Action and Mechanosensitive G Protein-Coupled Receptors. [PDF]

Int J Mol Sci
Cui ZJ, Huang WM, Li PJ, Xie XB.
europepmc   +1 more source